Emily Hays
Adult Health · Cincinnati, OHNPI 1801246236
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,290 and has fallen 90.7% since, to $120 in 2025.
Across 131 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$545
- Astellas Pharma US Inc$335
- Merck$241
- Braeburn Inc.$205
- AstraZeneca$202
- Novo Nordisk$178
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,72897%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 17 | $545 |
| Astellas Pharma US Inc | 15 | $335 |
| Merck | 15 | $241 |
| Braeburn Inc. | 2 | $205 |
| AstraZeneca | 7 | $202 |
| Novo Nordisk | 11 | $178 |
| Avanir Pharmaceuticals, Inc. | 5 | $145 |
| Boehringer Ingelheim | 11 | $144 |
| Exact Sciences | 7 | $129 |
| Novartis | 5 | $99 |
| Bayer | 6 | $95 |
| Nestle Healthcare Nutrition Inc. | 5 | $92 |
| Lilly USA, LLC | 5 | $81 |
| GSK | 4 | $60 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Amgen | 2 | $28 |
| Biogen | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,823 in reported general payments places this provider in the 85th percentile of 1,184 adult health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonidine | 13 | $2,188 |
| Potassium Chloride | 42 | $1,023 |
| Losartan Potassium | 23 | $529 |
| Omeprazole | 23 | $501 |
| Gabapentin | 19 | $426 |
| Finasteride | 13 | $280 |
| Donepezil Hcl | 12 | $245 |
| Levothyroxine Sodium | 14 | $171 |
Paid to pharmacies, not to this prescriber.
Other adult health in Cincinnati
- Andrew GuinigundoCincinnati$215K
- Mary Pat BartoszekCincinnati$38K
- Megan GieskeCincinnati$21K
- Melissa BrinkmanCincinnati$8K
- Bonnie MohlerCanton$338K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Teresa ShafferBoardman$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.